TY - JOUR
T1 - Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A
AU - Reinstein, Eyal
AU - Frentz, Sophia
AU - Morgan, Tim
AU - Garcia-Minãu R, Sixto
AU - Leventer, Richard J.
AU - McGillivray, George
AU - Pariani, Mitchel
AU - Van Der Steen, Anthony
AU - Pope, Michael
AU - Holder-Espinasse, Muriel
AU - Scott, Richard
AU - Thompson, Elizabeth M.
AU - Robertson, Terry
AU - Coppin, Brian
AU - Siegel, Robert
AU - Zurita, Montserrat Bret
AU - Rodriguez, Jose I.
AU - Morales, Carmen
AU - Rodrigues, Yuri
AU - Arcas, Joaquin
AU - Saggar, Anand
AU - Horton, Margaret
AU - Zackai, Elaine
AU - Graham, John M.
AU - Rimoin, David L.
AU - Robertson, Stephen P.
N1 - Funding Information:
The support of the Steven Spielberg Pediatric Research Center, the NIH/ NICHD Program Project Grant (HD36657), the Medical Genetics NIH/ NIGMS Training Program Grant (5-T32-GM08243), and the Cedars-Sinai General Clinical Research Center Grant (M01-RR00425) for samples collected under CSMC IRB Protocols 0463 and 4232 is acknowledged. SPR is supported by Curekids New Zealand and the Health Research Council of New Zealand. This paper is dedicated to the memory of David L Rimoin.
PY - 2013/5
Y1 - 2013/5
N2 - Mutations conferring loss of function at the FLNA (encoding filamin A) locus lead to X-linked periventricular nodular heterotopia (XL-PH), with seizures constituting the most common clinical manifestation of this disorder in female heterozygotes. Vascular dilatation (mainly the aorta), joint hypermobility and variable skin findings are also associated anomalies, with some reports suggesting that this might represents a separate syndrome allelic to XL-PH, termed as Ehlers-Danlos syndrome-periventricular heterotopia variant (EDS-PH). Here, we report a cohort of 11 males and females with both hypomorphic and null mutations in FLNA that manifest a wide spectrum of connective tissue and vascular anomalies. The spectrum of cutaneous defects was broader than previously described and is inconsistent with a specific type of EDS. We also extend the range of vascular anomalies associated with XL-PH to included peripheral arterial dilatation and atresia. Based on these observations, we suggest that there is little molecular or clinical justification for considering EDS-PH as a separate entity from XL-PH, but instead propose that there is a spectrum of vascular and connective tissues anomalies associated with this condition for which all individuals with loss-of-function mutations in FLNA should be evaluated. In addition, since some patients with XL-PH can present primarily with a joint hypermobility syndrome, we propose that screening for cardiovascular manifestations should be offered to those patients when there are associated seizures or an X-linked pattern of inheritance.
AB - Mutations conferring loss of function at the FLNA (encoding filamin A) locus lead to X-linked periventricular nodular heterotopia (XL-PH), with seizures constituting the most common clinical manifestation of this disorder in female heterozygotes. Vascular dilatation (mainly the aorta), joint hypermobility and variable skin findings are also associated anomalies, with some reports suggesting that this might represents a separate syndrome allelic to XL-PH, termed as Ehlers-Danlos syndrome-periventricular heterotopia variant (EDS-PH). Here, we report a cohort of 11 males and females with both hypomorphic and null mutations in FLNA that manifest a wide spectrum of connective tissue and vascular anomalies. The spectrum of cutaneous defects was broader than previously described and is inconsistent with a specific type of EDS. We also extend the range of vascular anomalies associated with XL-PH to included peripheral arterial dilatation and atresia. Based on these observations, we suggest that there is little molecular or clinical justification for considering EDS-PH as a separate entity from XL-PH, but instead propose that there is a spectrum of vascular and connective tissues anomalies associated with this condition for which all individuals with loss-of-function mutations in FLNA should be evaluated. In addition, since some patients with XL-PH can present primarily with a joint hypermobility syndrome, we propose that screening for cardiovascular manifestations should be offered to those patients when there are associated seizures or an X-linked pattern of inheritance.
KW - Ehlers-Danlos syndrome
KW - Filamin A
KW - Periventricular heterotopia
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=84876668033&partnerID=8YFLogxK
U2 - 10.1038/ejhg.2012.209
DO - 10.1038/ejhg.2012.209
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23032111
AN - SCOPUS:84876668033
SN - 1018-4813
VL - 21
SP - 494
EP - 502
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 5
ER -